StonvexLoading…
StonvexStonvexStonvexCore line items from PFSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.12M | $20.11M | $14.01M | $9.43M |
Operating Income | $104.69M | $551.42M | $417.01M | $180.64M |
Net Income | $82.32M | $501.08M | $394.25M | $212.74M |
EPS (Diluted) | $1.53 | $9.30 | $7.34 | $3.97 |
Total Assets | $31.94B | $29.39B | $25.40B | $24.22B |
Total Liabilities | $27.62B | $25.08B | $21.19B | $20.19B |
Cash & Equivalents | $219.51M | $301.68M | $621.92M | $162.19M |
Free Cash Flow OCF − CapEx | $-1.34B | $-1.66B | $233.52M | $932.97M |
Shares Outstanding | 51.92M | 52.06M | 51.88M | 51.67M |